JSAM
J. Safra Asset Management’s Alnylam Pharmaceuticals ALNY Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.26K | Hold |
7
| – | – | ﹤0.01% | 284 |
|
|
2025
Q1 | $1.89K | Hold |
7
| – | – | ﹤0.01% | 267 |
|
|
2024
Q4 | $1.65K | Hold |
7
| – | – | ﹤0.01% | 305 |
|
|
2024
Q3 | $1.92K | Buy |
+7
| New | +$1.92K | ﹤0.01% | 267 |
|
|
2023
Q4 | – | Sell |
-2
| Closed | -$354 | – | 128 |
|
|
2023
Q3 | $354 | Hold |
2
| – | – | ﹤0.01% | 103 |
|
|
2023
Q2 | $380 | Hold |
2
| – | – | ﹤0.01% | 97 |
|
|
2023
Q1 | $400 | Hold |
2
| – | – | ﹤0.01% | 98 |
|
|
2022
Q4 | $0 | Buy |
+2
| New | – | ﹤0.01% | 72 |
|